Directory

>

Michel Detheux

avatar

Michel Detheux

Chair Of The Board Of Directors | iTeos Therapeutics

Watertown, Massachusetts, United States

View contact details (it's free)

Michel Detheux

Summary

Michel Detheux is a seasoned executive in the biotechnology sector, with over three decades of experience spanning scientific research and business leadership. As the co-founder and CEO of iTeos Therapeutics, he has successfully navigated the company from its inception through significant funding rounds, including a NASDAQ IPO. His strategic acumen is demonstrated through a landmark deal with GlaxoSmithKline, aimed at co-developing innovative cancer therapies. Michel's academic credentials are robust, holding a Ph.D. in Biochemistry and a B.S. in Bioengineering, complemented by a postdoctoral fellowship in Parasitology. He is also an inventor with numerous patents and publications to his name, showcasing his commitment to advancing the field of cancer immunotherapy. His leadership extends beyond iTeos, serving on the boards of various organizations, indicating a strong network and influence in the biotech community. Michel's diverse experience in both startup environments and established organizations positions him as a key player in shaping the future of biopharmaceuticals.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Startup Experience

Corporate Experience

Consulting Experience

Michel Detheux

Work Experience

company logo

Chair Of The Board Of Directors at

EGLE THERAPEUTICS

August 2024 - Present

company logo

Chair Of The Board Of Directors at

ONA Therapeutics

September 2021 - Present

company logo

Co-founder, President & CEO at

iTeos Therapeutics

March 2019 - Present

💼

Chair Of The Board Of Directors at

INNOSKEL

March 2022 - July 2023

💼

Founder and Managing Director at

MG6A Bioconsulting

January 2012 - February 2019

company logo

Co-founder & CEO* at

iTeos Therapeutics

April 2012 - February 2019

company logo

Director of the Board* at

BioWin

September 2016 - September 2018

💼

Independent Board Member* at

IMMUNEHEALTH LTD

September 2014 - September 2016

company logo

Director, Spin off project at

Ludwig Institute For Cancer Research

December 2010 - April 2012

💼

Director Euroscreen FAST Business Unit at

EuroScreen Építöipari, Kereskedelmi es Szolgaltató Korlatolt Felelössegu Tarsasag

September 2006 - November 2010

💼

Manager, New Business Opportunities at

EuroScreen Építöipari, Kereskedelmi es Szolgaltató Korlatolt Felelössegu Tarsasag

January 2005 - September 2006

💼

Head of Target Discovery at

EuroScreen Építöipari, Kereskedelmi es Szolgaltató Korlatolt Felelössegu Tarsasag

April 1995 - January 2004

company logo

Post doctoral fellow at

University of Glasgow Trust

January 1993 - January 1994

Logos provided by Logo.dev

Michel Detheux

Education

Solvay Brussels School of Economics and Management , Cepac

January 2001 - January 2002

University of Law, Post Doc

January 1993 - January 1994

UCLouvain, Phd

January 1989 - January 1993

UCLouvain, Chemical Engineer

January 1984 - January 1989

Frequently Asked Questions about Michel Detheux

What is Michel Detheux email address?

Michel Detheux's primary email address is ********@iteostherapeutics.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Michel Detheux work for?

Michel Detheux is a Chair Of The Board Of Directors at iTeos Therapeutics, a company specializing in Commercial physical research.

Where Michel Detheux graduated from?

Michel Detheux holds a degree in Business/Management from Solvay Brussels School of Economics and Management .

How can I directly contact Michel Detheux?

To contact Michel Detheux directly, you can use the email address ********@iteostherapeutics.com. Complete contact information is available upon registration with Muraena.

Who is Michel Detheux?

Michel Detheux is a seasoned executive in the biotechnology sector, with over three decades of experience spanning scientific research and business leadership. As the co-founder and CEO of iTeos Therapeutics, he has successfully navigated the company from its inception through significant funding rounds, including a NASDAQ IPO. His strategic acumen is demonstrated through a landmark deal with GlaxoSmithKline, aimed at co-developing innovative cancer therapies. Michel's academic credentials are robust, holding a Ph.D. in Biochemistry and a B.S. in Bioengineering, complemented by a postdoctoral fellowship in Parasitology. He is also an inventor with numerous patents and publications to his name, showcasing his commitment to advancing the field of cancer immunotherapy. His leadership extends beyond iTeos, serving on the boards of various organizations, indicating a strong network and influence in the biotech community. Michel's diverse experience in both startup environments and established organizations positions him as a key player in shaping the future of biopharmaceuticals.

Michel`s contact details

mail

********@iteostherapeutics.com

******@ona-therapeutics.com

Colleagues

avatar
Pmp Sandrine Segura Gozzini

VP, Global Head of CMC

avatar
Adi Osovsky

Executive Vice President, Head of Legal and Corporate Secretary

avatar
Philippe Brantegem

Executive Vice President Human Resources

avatar
Sally Ross

VP Project Head

avatar
Laurent Kerstens

Chief Accountant

avatar
Scott Moren

VP, Medical Affairs

avatar
David Hallal

Executive Chairman

avatar
Jeri Kim

Vice President Clinical Development

avatar
Gabriela Rossi

Vice President, Regulatory Affairs

avatar
Chad Stewart

Vice President & Head of Project Management

View Contact details (it's free)
Request Profile Removal